• OPEN AN ACCOUNT
Indian Indices
Nifty
24,718.60 -169.60
(-0.68%)
Sensex
81,118.60 -573.38
( -0.70%)
Bank Nifty
55,527.35 -555.20
( -0.99%)
Nifty IT
38,469.25 8.95
( 0.02%)
Global Indices
Nasdaq
42,214.73 -773.90
(-1.80%)
Dow Jones
5,997.34 -68.92
(-1.14%)
Hang Seng
37,801.43 -371.66
(-0.97%)
Nikkei 225
8,850.63 -34.29
(-0.39%)
Forex
USD-INR
85.55 0.07
(0.08%)
EUR-INR
98.89 0.98
(1.00%)
GBP-INR
116.24 0.70
(0.61%)
JPY-INR
0.60 0.01
(0.86%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
30.5295026
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
62.45
11743.74
EPS(TTM)
Face Value()
Div & Yield %
4.15
1
0.31
 

As on: Jun 13, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
259.15 -1.45 128765 62.45
Stock Price Details
Open Price() 251.70
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 259.95
Today's Low () 249.90
52-Week High () 358.5
152-Week Low () 155.55
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.31
Eps 4.15
Book Value 30.5295026
Market Cap (.Cr) 11,743.74
Face Value 1
Market Lot 1
AGM Date Sep
Book Closure Date
ISIN No. INE750C01026


News
Relonchem receives marketing authorization for Metformin Hydrochloride 500mg/ 5 ml Oral Solution in UK
Marksans Pharma gets regulatory nod for marketing type-2 diabetes medication in UK
Marksans Pharma Ltd - Marksans Pharma Limited - Press Release
Marksans Pharma Ltd - Marksans Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Marksans Pharma Ltd - Marksans Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Marksans Pharma Ltd - Marksans Pharma Limited - Copy of Newspaper Publication
Marksans Pharma Ltd - Marksans Pharma Limited - Copy of Newspaper Publication
Marksans Pharma Ltd - Marksans Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Marksans Pharma consolidated net profit rises 15.66% in the March 2025 quarter
Board of Marksans Pharma recommends final dividend
More
Corporate Details
Incoporation Year   : 1992
Chairman : Mark Saldanha
Bussiness Group : Indian Private
Registered Office
Marksans Pharma Ltd
11th Flr GRANDEUR Oshiwara,
Veera Desai Extn Rd Andheri(W),
Mumbai,
Maharashtra-400053
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-40012000
Fax:91-22-40012011
Fax:91-22-66317458
E-Mail : companysecretary@marksanspharma.com ; info@marksan
URL : http://www.marksanspharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE HC
  • BSE SmallCap
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi